Speaker Profile
Ph.D., Founder and CEO, Portal Biotech
Biography
Armon Sharei has built a scalable technology platform that enables efficient intracellular delivery for cell engineering and drug discovery. He has led the development and commercialization of mechanoporation technologies that support high-throughput, reproducible workflows, serving a growing customer base across biopharma and clinical research. Previously, he founded and scaled a biotechnology company from inception through public markets, raising over $300 million, advancing multiple oncology programs into the clinic, and establishing a multibillion-dollar strategic collaboration with Roche. His work spans invention, company building, and the translation of complex engineering into practical biological tools. He is an inventor on more than 30 patents and is widely recognized for bridging deep technical innovation with real-world impact in the life sciences.
Talk
Ridiculously Simple, Scalable Cell Engineering
Portal is building the universal infrastructure for advanced cell engineering. Our platform enables scalable, multimodal modification of hard-to-transfect cells beyond traditional limits, generating high-dimensional, multiplexed perturbation data. Trusted by top pharma, Portal powers programmable cell therapies and produces the datasets needed to train AI models that decode complex cellular systems and accelerate precision medicine.
Emerging Therapeutics Showcase:
Portal Biotechnologies
Portal is building the universal infrastructure for cell engineering across drug discovery and cell therapy. Its proprietary mechanical delivery platform enables scalable, multimodal modification of hard-to-transfect cells, empowering top pharma and biotech to run more predictive screens, multi-engineer therapeutic cells, and advance toward future point-of-care manufacturing.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
